Related Experiment Video
Updated: Nov 17, 2025

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
COVID-19 Vaccination Intent, Perceptions, and Reasons for Not Vaccinating Among Groups Prioritized for Early
Insights
COVID-19 vaccine intent increased from September to December 2020. Efforts are needed to boost vaccine confidence, especially among younger adults and minority groups, to ensure equitable vaccination coverage.
Area of Science:
- Public Health
- Epidemiology
- Vaccinology
Background:
- Widespread COVID-19 vaccine distribution began in late 2020.
- Pre-vaccination polls indicated significant vaccine hesitancy among the U.S. population.
- Understanding public perception and vaccination intent is crucial for pandemic control.
Purpose of the Study:
- To assess U.S. adults' perceptions of COVID-19 vaccines.
- To track changes in vaccination intent from September to December 2020.
- To identify demographic disparities in vaccine hesitancy.
Main Methods:
- Conducted representative national household panel surveys.
- Collected data in September and December 2020.
- Analyzed vaccination intent and nonintent across sociodemographic groups.
Main Results:
- Overall vaccination intent increased from 39.4% to 49.1% (or 61.9% to 68.0% with broader definition).
- Vaccination nonintent decreased across most groups.
- Significant intent increases observed in adults aged ≥65, essential workers, and those with underlying conditions.
- Younger adults, women, Black individuals, and those with lower socioeconomic status showed higher nonintent.
Conclusions:
- COVID-19 vaccine confidence and intent improved between September and December 2020.
- Targeted strategies are necessary to address persistent hesitancy in specific subpopulations.
- Achieving high and equitable vaccination coverage is vital for mitigating the COVID-19 pandemic.
Abstract:
As of February 8, 2021, 59.3 million doses of vaccines to prevent coronavirus disease 2019 (COVID-19) had been distributed in the United States, and 31.6 million persons had received at least 1 dose of the COVID-19 vaccine (1). However, national polls conducted before vaccine distribution began suggested that many persons were hesitant to receive COVID-19 vaccination (2). To examine perceptions toward COVID-19 vaccine and intentions to be vaccinated, in September and December 2020, CDC conducted household panel surveys among a representative sample of U.S. adults. From September to December, vaccination intent (defined as being absolutely certain or very likely to be vaccinated) increased overall (from 39.4% to 49.1%); the largest increase occurred among adults aged ≥65 years. If defined as being absolutely certain, very likely, or somewhat likely to be vaccinated, vaccination intent increased overall from September (61.9%) to December (68.0%). Vaccination nonintent (defined as not intending to receive a COVID-19 vaccination) decreased among all adults (from 38.1% to 32.1%) and among most sociodemographic groups. Younger adults, women, non-Hispanic Black (Black) persons, adults living in nonmetropolitan areas, and adults with lower educational attainment, with lower income, and without health insurance were most likely to report lack of intent to receive COVID-19 vaccine. Intent to receive COVID-19 vaccine increased among adults aged ≥65 years by 17.1 percentage points (from 49.1% to 66.2%), among essential workers by 8.8 points (from 37.1% to 45.9%), and among adults aged 18-64 years with underlying medical conditions by 5.3 points (from 36.5% to 41.8%). Although confidence in COVID-19 vaccines increased during September-December 2020 in the United States, additional efforts to tailor messages and implement strategies to further increase the public's confidence, overall and within specific subpopulations, are needed. Ensuring high and equitable vaccination coverage across all populations is important to prevent the spread of COVID-19 and mitigate the impact of the pandemic.
Related Concept Videos
Vaccinations
Bias in Epidemiological Studies
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Preventive Healthcare Services
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

